With the idea of demonstrating the evolution of modern machining with the help of IMTS 2026 in Chicago, SW North America ...

Xaira Therapeutics today announced the appointment of Ian McCaffery, Ph.D., as Senior Vice President, Translational Science and Early Clinical Development, and the promotions of Ci Chu, Ph.D., to ...

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb), is the world's deadliest single-agent infection, responsible for 1.23 million deaths in 2024, according to the World Health ...

Beyond Installation, Operational, and Performance Qualifications: A Risk-Based Validation Framework for AI-Driven Software in ...

A research team led by UMass Amherst has developed two new techniques to significantly speed up the search for effective ...

The temptation with a car like the Czinger 21C is to treat it as a collection of extreme specifications, and to be fair, it’s ...

A less invasive brain-computer interface is being developed to help people with impaired speech, including ALS, communicate.

A new AI model called COMPASS uses tumor gene expression data to predict which patients will respond to cancer immunotherapy ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced the publication of new data in JAMA Oncology, evaluating the utility of Signatera, its personalized molecular ...

AMHERST, Mass. — Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) is the world's deadliest single-agent caused infection ...

American Fusion Inc. (OTC: AMFN) (profile), through its wholly owned subsidiary, Kepler Fusion(TM), is developing the Texatron(TM), a compact, aneutronic (little to no radiation) truck-deployable ...

Jiahui International Cancer Center (JICC) has welcomed the world's first international patient to begin treatment with Satri-cel, the world's first approved CAR-T therapy for a solid tumor, marking a ...